Generic Drug Market 2010

Language:
Japanese
Product Code No:
C52103300
Issued In:
2010/09
#of Pages:
332
Publication Cycle:
Biannual
Format:
PDF

Price

120,000 yen ($1,099.40)
(excluding consumption tax)
240,000 yen ($2,198.81)
(excluding consumption tax)
360,000 yen ($3,298.21)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 109.15 yen , 2020/04/07 Japan)

Coverage: (Product/service)

Generic drugs

Research Target:

Generic drug manufacturers, pharmaceutical companies, medical institutions

Research Content:

Chapter 1: Generic Drug Market Overview and Trends
Promotions to use generic drugs by the government and municipal bodies, health insurance reimbursement revision and dispensing pharmacies, DPC, brand strategies, generic pharma, road map, Japan Generic Medicines Association, Nihon Generic Iyakuhin Hansha Kyokai, distribution, wholesaler channel, trading firm, patent expiration, forecast of market size
 
Chapter 2: Generic Drug Strategies of Pharmaceutical Companies
Intensified competitions, business size, sales ranking, industry reorganization, polarization and small manufacturers, overseas companies, including European, US and Indian companies, market expansion and amendment of Pharmaceutical Affairs Law, risk distribution management, medium standing pharmaceutical companies, R&D and capital investment, production capacity, relationship with wholesalers, medical representatives and marketing, differentiation strategies, pricing, product lineup and business strategies, classification of generic drug manufacturers
 
Chapter 3: Generic Drug Manufacturer Trends
Actavis Aska, Kowa Teva, Sawai Pharmaceutical, Taiyo Yakuhin, Towa Pharmaceutical, Nichi-Iko Pharmaceutical, Nissin Pharmaceutical, Nipro Pharma, Nippon Chemiphar, Nihon Generic, Fuji Pharma, Fujifilm Pharma, Hospira Japan, Meiji Seika
 
Chapter 4: Adoption of Generic Drugs by Hospitals and Dispensing Pharmacies
Public hospitals and municipal bodies, dispensing pharmacies, national hospitals, DPC hospitals, medium-size hospitals, anti-cancer agents
 
Chapter 5: Biosimilar Business Trends
Increase in announcements of market entries, guideline, drug price, global companies, dedicated generic drug manufacturers, medium standing new drug manufacturers, development and information dissemination system

Price

written in Japanese
120,000 yen ($1,099.40)
(excluding consumption tax)
240,000 yen ($2,198.81)
(excluding consumption tax)
360,000 yen ($3,298.21)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 109.15 yen , 2020/04/07 Japan)